The presence of intraductal carcinoma of prostate is a risk factor for poor pathologic response in men with high-risk prostate cancer receiving neoadjuvant therapy
-
Published:2024-01
Issue:
Volume:
Page:
-
ISSN:1078-1439
-
Container-title:Urologic Oncology: Seminars and Original Investigations
-
language:en
-
Short-container-title:Urologic Oncology: Seminars and Original Investigations
Author:
Wang Binyu,
Fu Yao,
Chen Mengxia,
Peng Shan,
Marra Giancarlo,
Zhuang Junlong,
Zhang Shiwei,
Guo Hongqian,
Qiu XuefengORCID